29th Annual TNP Conference Workshop S28 Evaluation - Update on Cystic Fibrosis

Speaker: Kimberly English
Saturday, September 9, 2017

Question Title

S28: As a result of my participation in the Update on Cystic Fibrosis, I am better to:

  Strongly Disagree Disagree Agree Strongly Agree
Discuss pathophysiology of cystic fibrosis
Review current pulmonary therapies (non pharmacological and pharmacological) for cystic fibrosis patients (RX)
Review new therapies for the treatment of cystic fibrosis patients (RX)
Q & A including pharmacology (RX)

Question Title

The teaching methods used were appropriate to the objectives.

Question Title

Kimberly English demonstrated experimental knowledge of the topic.

Question Title

The individual objectives/content topic were cohesive with one another.

Question Title

The content of the program was balanced and free of commercial bias.

Question Title

Speaker(s) fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation.

Question Title

I would recommend this speaker for future conference.

T